SOLID TUMOR SHOW TO EXPRESS DLL3

Clinical trials for SOLID TUMOR SHOW TO EXPRESS DLL3 explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMOR SHOW TO EXPRESS DLL3 trials appear

Sign up with your email to follow new studies for SOLID TUMOR SHOW TO EXPRESS DLL3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets aggressive lung cancers

Disease control Recruiting now

This study is testing a new drug called IDE849 for people with certain aggressive cancers, including small cell lung cancer, that have a specific marker called DLL3. The research aims to find safe doses and see if the drug can shrink tumors, either alone or combined with other me…

Matched conditions: SOLID TUMOR SHOW TO EXPRESS DLL3

Phase: PHASE1, PHASE2 • Sponsor: IDEAYA Biosciences • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

SOLID TUMOR SHOW TO EXPRESS DLL3

Get alerted when new SOLID TUMOR SHOW TO EXPRESS DLL3 trials appear

New drug trial targets aggressive lung cancers